A Phase 2 Randomized, Placebo-controlled Crossover Trial to Evaluate Safety and Efficacy of Platelet-rich Plasma Injections for Peyronie's Disease: Clinical Trial Update.
Saved in:
| Title: | A Phase 2 Randomized, Placebo-controlled Crossover Trial to Evaluate Safety and Efficacy of Platelet-rich Plasma Injections for Peyronie's Disease: Clinical Trial Update. |
|---|---|
| Authors: | Chu KY; Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Molina ML; Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Ledesma B; Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Zucker I; Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Saltzman RG; Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Masterson TA; Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA., Ramasamy R; Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: ramasamy@miami.edu. |
| Source: | European urology focus [Eur Urol Focus] 2023 Jan; Vol. 9 (1), pp. 11-13. Date of Electronic Publication: 2022 Sep 10. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2405-4569 |
|---|---|
| DOI: | 10.1016/j.euf.2022.08.017 |
